
A UK inquiry into common pet parasite treatments has found that their widespread use lacks strong scientific backing. The report highlights that two chemicals frequently used in these medications are already banned in agriculture due to their harmful effects on insects like bees.
Read More
Due to the toxicity of these medications, particularly in aquatic environments, and limited information regarding their impact on humans, the report recommends implementing restrictions until their effects are thoroughly evaluated.
Following the report, the Science Media Centre (SMC) sought expert opinions on the use of these treatments in New Zealand and their potential effects on the local ecosystem.
Chloe McMenamin, a lecturer and researcher at the School of Environmental and Animal Sciences at Unitec, stated that the routine over-the-counter sale of flea and tick treatments is increasingly difficult to justify given the mounting scientific evidence. She emphasized that while protecting pets from parasites is essential, these products do not simply disappear once applied. McMenamin and colleagues have detected chemicals such as imidacloprid, fipronil, and fluralaner in New Zealand’s wastewater systems at concentrations likely to have ecological impacts.
She noted that international studies have found these chemicals not only in bird nests—where fur collected from the ground is used—but also in unhatched eggs, dead chicks, and aquatic environments, often exceeding safety thresholds for aquatic life.
Dr. Joanne Clapcott, President of the New Zealand Freshwater Sciences Society, commented on the additional pressures that these medications could place on New Zealand’s already strained rivers. She called for continued investment in freshwater monitoring to understand the ecological significance of these emerging contaminants better and to make informed management decisions.
Professor Melanie Kah from the University of Auckland indicated that the UK report calls for tighter regulations on pet parasite medications due to their overuse and the potential risks they pose to pets, humans, and the environment. She expressed an interest in assessing the impact of these medications in New Zealand, where pet ownership is high.
Veterinarian Siobhan Ellis acknowledged the importance of discussing this issue. She supports increased research and education regarding the environmental impacts of flea and parasite treatments while recognizing the health benefits of these medications. Ellis noted a shift in veterinary preferences towards newer treatments, whose environmental impacts are not yet well understood.
Experts from the UK also provided insights. Professor Oliver Jones, an Australian chemist, stated that there is strong evidence that pet medications enter the environment but the consequences of their presence remain uncertain. He emphasized the necessity for data collection to balance pet health treatments against potential environmental risks.
Professor Leon Barron from Imperial College London remarked on the consistent risk that pet medications pose to aquatic life in UK waterways and underscored that most contamination comes from domestic wastewater after these products wash off pets.
In conclusion, while pet flea and tick treatments are important for pet health, the evidence suggests that their environmental impacts warrant closer scrutiny and potentially stricter regulation.